But the new drug has fewer side effects, claims an article published Online and in an upcoming edition of The Lancet.
Infections caused by Candida fungi have become increasingly prevalent in recent years, and problems associated with long established treatments are well known.
Researchers led by Oliver Cornely, of The University Hospital of Cologne, Germany, tested the effectiveness of two well known treatments, liposomal amphotericin B and micafungin, against the common infections candidaemia and invasive candidosis.
A total of 531 patients with these infections were split into two groups and given either micafungin 100mg per day or liposomal amphotericin B 3mg per kg body weight daily. The success rate of both drugs was almost exactly the same – 89.6% for micofungin versus 89.6% for liposomal amphotericin B.
The effectiveness of either treatment was independent of primary site of infection and the patient’s immune status, and whether or not a catheter had been fitted during treatment.
But micafungin produced fewer treatment related side effects than liposomal amphotericin B. Increased problems with kidney function, as well as higher occurrence of problems during drug administration, were observed in the patients receiving liposomal amphotericin B.
The authors conclude: “Our results establish micafungin as a treatment option for first-line therapy of candidaemia and invasive candidosis.”
They add: “Micafungin also has broad-spectrum activity against Aspergillosis spp, thus to assess its efficacy in the treatment of invasive aspergillosis will be an important future goal.”
Tony Kirby | alfa
Organ-on-a-chip mimics heart's biomechanical properties
23.02.2017 | Vanderbilt University
Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München
On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded after a glide flight with an Airbus A320 in ditching on the Hudson River. All 155 people on board were saved.
On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded...
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
27.02.2017 | Materials Sciences
27.02.2017 | Interdisciplinary Research
27.02.2017 | Life Sciences